| Assay ID | Title | Year | Journal | Article |
|---|
| AID509711 | Antibacterial activity against Salmonella typhi at 50 ug/ml after 24 hrs by agar cup diffusion method | 2010 | European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
| Synthesis of some 3-substituted amino-4,5-tetramethylene thieno[2,3-d][ 1,2,3]-triazin-4(3H)-ones as potential antimicrobial agents. |
| AID509703 | Antibacterial activity against Escherichia coli after 24 hrs by tube dilution method | 2010 | European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
| Synthesis of some 3-substituted amino-4,5-tetramethylene thieno[2,3-d][ 1,2,3]-triazin-4(3H)-ones as potential antimicrobial agents. |
| AID509709 | Antibacterial activity against Staphylococcus epidermidis at 50 ug/ml after 24 hrs by agar cup diffusion method | 2010 | European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
| Synthesis of some 3-substituted amino-4,5-tetramethylene thieno[2,3-d][ 1,2,3]-triazin-4(3H)-ones as potential antimicrobial agents. |
| AID509704 | Antibacterial activity against Salmonella typhi after 24 hrs by tube dilution method | 2010 | European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
| Synthesis of some 3-substituted amino-4,5-tetramethylene thieno[2,3-d][ 1,2,3]-triazin-4(3H)-ones as potential antimicrobial agents. |
| AID509701 | Antibacterial activity against Staphylococcus aureus after 24 hrs by tube dilution method | 2010 | European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
| Synthesis of some 3-substituted amino-4,5-tetramethylene thieno[2,3-d][ 1,2,3]-triazin-4(3H)-ones as potential antimicrobial agents. |
| AID509702 | Antibacterial activity against Staphylococcus epidermidis after 24 hrs by tube dilution method | 2010 | European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
| Synthesis of some 3-substituted amino-4,5-tetramethylene thieno[2,3-d][ 1,2,3]-triazin-4(3H)-ones as potential antimicrobial agents. |
| AID509707 | Antifungal activity against Cryptococcus neoformans after 48 hrs by tube dilution method | 2010 | European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
| Synthesis of some 3-substituted amino-4,5-tetramethylene thieno[2,3-d][ 1,2,3]-triazin-4(3H)-ones as potential antimicrobial agents. |
| AID509705 | Antifungal activity against Aspergillus niger after 48 hrs by tube dilution method | 2010 | European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
| Synthesis of some 3-substituted amino-4,5-tetramethylene thieno[2,3-d][ 1,2,3]-triazin-4(3H)-ones as potential antimicrobial agents. |
| AID509708 | Antibacterial activity against Staphylococcus aureus at 50 ug/ml after 24 hrs by agar cup diffusion method | 2010 | European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
| Synthesis of some 3-substituted amino-4,5-tetramethylene thieno[2,3-d][ 1,2,3]-triazin-4(3H)-ones as potential antimicrobial agents. |
| AID509712 | Antifungal activity against Aspergillus niger at 50 ug/ml after 48 hrs by agar cup diffusion method | 2010 | European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
| Synthesis of some 3-substituted amino-4,5-tetramethylene thieno[2,3-d][ 1,2,3]-triazin-4(3H)-ones as potential antimicrobial agents. |
| AID509710 | Antibacterial activity against Escherichia coli at 50 ug/ml after 24 hrs by agar cup diffusion method | 2010 | European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
| Synthesis of some 3-substituted amino-4,5-tetramethylene thieno[2,3-d][ 1,2,3]-triazin-4(3H)-ones as potential antimicrobial agents. |
| AID509706 | Antifungal activity against Candida albicans after 48 hrs by tube dilution method | 2010 | European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
| Synthesis of some 3-substituted amino-4,5-tetramethylene thieno[2,3-d][ 1,2,3]-triazin-4(3H)-ones as potential antimicrobial agents. |
| AID509713 | Antifungal activity against Candida albicans at 50 ug/ml after 48 hrs by agar cup diffusion method | 2010 | European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
| Synthesis of some 3-substituted amino-4,5-tetramethylene thieno[2,3-d][ 1,2,3]-triazin-4(3H)-ones as potential antimicrobial agents. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |